PBS Biotech specializes in scalable single-use bioreactors for cell therapy applications. The company enables the manufacturing of various cell therapies derived from different types of stem cells.

PBS Biotech

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

Google Analytics

Chief Executive Officer

Brian Lee

Quality

Erica Ponce

Sr. Director of Engineering

Gary Evans

Director of Information Technology

Matthew Walker

Sr. Director Quality Engineering and Regulatory

Rodney Torres

Sr. Director Supply Chain

Roger de Almeida Felix

Executive Director, Quality

Scott Summersgill

Director, Marketing and Product Management

Sharon Harvey

Executive Director, Bioprocess Research & Development

Sunghoon Jung

Jerry Liao

Gregory Zeikus

Co-Founder

CEO and Co-Founder

United States Companies With Fewer Than 1000 Employees (Top 10K)

United States Companies With More Than 10 Employees (Top 10K)

Biotechnology Companies With Less Than $10M in Revenue (Top 10K)

California Companies With Less Than $500M in Revenue (Top 10K)

PBS Biotech offers single-use bioreactors and process development services for cell product manufacturing. Their single-use bioreactors have the smallest per liter volume footprints and are fully scalable for any stage of the cell culture process, from R&D to clinical to cGMP production. They provide efficient, cost-effective disposable systems and top-notch technical services to help their customers solve complex cell culture challenges.

Venture Round - PBS Biotech

Avego Management

BroadOak Capital Partners

Computer and Software Products and Electrical and Scientific Products

Camarillo

California

United States

North America

Single Use System In Biopharma Manufacturing Market- Increasing Demand with Industry Professionals

PBS Biotech Earns ISO 9001:2015 Certification, Demonstrating Commitment to Quality

Perfusion Bioreactor Market Size to Grow USD 1270.7 Million by 2029 at a CAGR of 9.3% | Valuates Reports

Single-Use Bioreactors Gain Popularity Worldwide

Genelux Corporation Announces New Chief Financial Officer

Europe Single-use Bioreactors Market to be Worth $3.34 ...

Global Single-use Bioreactors Market Report 2023: Sector is ...

Bioreactors designed for cell therapy manufacturing, available in various sizes for different stages of process development and commercial production.

Services offered to develop scalable cell culture processes tailored to specific therapeutic cell types and manufacturing requirements.

A small-scale bioreactor for early process development, available in 0.1 and 0.5 L working volumes.

A bioreactor with a 3L maximum working volume, suitable for advancing process development.

A 15L bioreactor designed for scaling up cell culture processes to clinical stage production.

An 80L bioreactor for commercial-scale manufacturing of cell therapy products.

China

Asia

Finland

Europe

India

Indonesia

HTML5

jQuery

Google Fonts

Fonts.com

DigiCert

Microsoft Outlook

Google Drive

Apache Server

Adobe Fonts

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 8:15 AM	ea203ad8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 8:15 AM	b4614bf6
crunchbase trigger	general	Nov 19, 2024 8:15 AM	cb093ef0
crunchbase profile	general	Nov 20, 2024 12:27 AM	cc014dc1
li profile	general	Nov 19, 2024 8:15 AM	4bf65d03
translate crunchbase fundingrounds	general	Nov 20, 2024 1:22 AM	c95e1fe3
peers	general	Nov 19, 2024 8:15 AM	11e2cb42
news basic	general	Nov 19, 2024 8:15 AM	5b1e8db1
bundesanzeiger	filings
financials download nd	financials
private financials	financials

PBSB

COM:PBSBIOTECH

PBS Biotech